Taxotere® can induce nails changes like dyschromia, hematoma, lines of Beau-Reil (signing the stop of the epithelial proliferation), abscess, or pain. In this context, this randomized, monocentric phase III trial evaluates the cryotherapy, using frozen glove, in the prevention of nails toxicity induced by Taxotere® in patient treated for breast or prostate cancer. Primary objective: Demonstrate a reduction of the nails toxicity using frozen glove during chemotherapy with Taxotere®. Secondary objectives: Analysis of time of protection against onycholysis Estimation of the efficiency of cryotherapy, and impact on quality of life Tolerance and compliance of the frozen glove
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Enrollment
168
Using frozen glove during chemotherapy with Taxotere®
Institut PAOLI-CALMETTES
Marseille, France
Number of patients treated by Taxotere® with nail toxicity >= 2 (CTC-AE version 3.0)
Time frame: 4 months
Number of day between inclusion and apparition of nail toxicity
Time frame: 4 months
Necessity of local care, existence of pains
Time frame: 4 months
Tolerance and compliance for the frozen glove
Time frame: 4 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.